Deep learning to distinguish benign from malignant renal lesions based on routine MR imaging.

CONCLUSIONS: Deep learning can non-invasive distinguish benign renal tumors from RCC using conventional MR imaging in a multi-institutional dataset with good accuracy, sensitivity and specificity comparable to experts and radiomics.
PMID: 31937619 [PubMed - as supplied by publisher]

Source: Clinical Cancer Research - January 13, 2020 Category: Cancer & Oncology Authors: Xi IL, Zhao Y, Wang R, Chang M, Purkayastha S, Chang K, Huang RY, Silva AC, Vallières M, Habibollahi P, Fan Y, Zou B, Gade TP, Zhang PJ, Soulen MC, Zhang Z, Bai HX, Stavropoulos SW Tags: Clin Cancer Res Source Type: research